nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.0994	0.594	CrCrCtD
Imipramine—HTR2C—type 2 diabetes mellitus	0.082	0.328	CbGaD
Imipramine—Benazepril—Ramipril—type 2 diabetes mellitus	0.0678	0.406	CrCrCtD
Imipramine—CYP2E1—type 2 diabetes mellitus	0.065	0.26	CbGaD
Imipramine—CYP1A2—type 2 diabetes mellitus	0.0618	0.248	CbGaD
Imipramine—CYP3A4—type 2 diabetes mellitus	0.0409	0.164	CbGaD
Imipramine—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0299	0.0845	CbGbCtD
Imipramine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0231	0.0651	CbGbCtD
Imipramine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0202	0.0571	CbGbCtD
Imipramine—ORM1—Nateglinide—type 2 diabetes mellitus	0.0187	0.0529	CbGbCtD
Imipramine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0177	0.0499	CbGbCtD
Imipramine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0129	0.0364	CbGbCtD
Imipramine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0118	0.0332	CbGbCtD
Imipramine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0111	0.0313	CbGbCtD
Imipramine—SLC22A3—Metformin—type 2 diabetes mellitus	0.0107	0.0303	CbGbCtD
Imipramine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0106	0.0299	CbGbCtD
Imipramine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0102	0.0287	CbGbCtD
Imipramine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00976	0.0276	CbGbCtD
Imipramine—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00845	0.0239	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00845	0.0239	CbGbCtD
Imipramine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00845	0.0239	CbGbCtD
Imipramine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00794	0.0224	CbGbCtD
Imipramine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00753	0.0213	CbGbCtD
Imipramine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00675	0.019	CbGbCtD
Imipramine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00675	0.019	CbGbCtD
Imipramine—SLC22A2—Metformin—type 2 diabetes mellitus	0.00634	0.0179	CbGbCtD
Imipramine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00623	0.0176	CbGbCtD
Imipramine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00601	0.017	CbGbCtD
Imipramine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00575	0.0162	CbGbCtD
Imipramine—SLC22A1—Metformin—type 2 diabetes mellitus	0.00551	0.0156	CbGbCtD
Imipramine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00544	0.0154	CbGbCtD
Imipramine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00513	0.0145	CbGbCtD
Imipramine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00506	0.0143	CbGbCtD
Imipramine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00473	0.0134	CbGbCtD
Imipramine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00452	0.0128	CbGbCtD
Imipramine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00451	0.0127	CbGbCtD
Imipramine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00428	0.0121	CbGbCtD
Imipramine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00413	0.0116	CbGbCtD
Imipramine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00389	0.011	CbGbCtD
Imipramine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00374	0.0106	CbGbCtD
Imipramine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00373	0.0105	CbGbCtD
Imipramine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00361	0.0102	CbGbCtD
Imipramine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00345	0.00975	CbGbCtD
Imipramine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00326	0.00921	CbGbCtD
Imipramine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00316	0.00892	CbGbCtD
Imipramine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00292	0.00823	CbGbCtD
Imipramine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00279	0.00787	CbGbCtD
Imipramine—ABCB1—Losartan—type 2 diabetes mellitus	0.00255	0.0072	CbGbCtD
Imipramine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00247	0.00698	CbGbCtD
Imipramine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00237	0.00669	CbGbCtD
Imipramine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00237	0.00669	CbGbCtD
Imipramine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00224	0.00633	CbGbCtD
Imipramine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00167	0.00471	CbGbCtD
Imipramine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00154	0.0525	CbGeAlD
Imipramine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00153	0.00431	CbGbCtD
Imipramine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00149	0.0506	CbGeAlD
Imipramine—HTR2A—arteriole—type 2 diabetes mellitus	0.00145	0.0495	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00104	0.0353	CbGeAlD
Imipramine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.000999	0.034	CbGeAlD
Imipramine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000927	0.0315	CbGeAlD
Imipramine—SLC6A3—nerve—type 2 diabetes mellitus	0.000723	0.0246	CbGeAlD
Imipramine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000721	0.0245	CbGeAlD
Imipramine—KCND3—islet of Langerhans—type 2 diabetes mellitus	0.000687	0.0234	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000623	0.0212	CbGeAlD
Imipramine—SLC6A2—nerve—type 2 diabetes mellitus	0.000583	0.0198	CbGeAlD
Imipramine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000576	0.0196	CbGeAlD
Imipramine—KCND2—cardiovascular system—type 2 diabetes mellitus	0.00057	0.0194	CbGeAlD
Imipramine—HTR7—artery—type 2 diabetes mellitus	0.000567	0.0193	CbGeAlD
Imipramine—HTR7—nerve—type 2 diabetes mellitus	0.000562	0.0191	CbGeAlD
Imipramine—DRD2—nerve—type 2 diabetes mellitus	0.000531	0.0181	CbGeAlD
Imipramine—KCND2—adipose tissue—type 2 diabetes mellitus	0.000503	0.0171	CbGeAlD
Imipramine—KCND3—cardiovascular system—type 2 diabetes mellitus	0.000497	0.0169	CbGeAlD
Imipramine—KCND3—pancreas—type 2 diabetes mellitus	0.000483	0.0164	CbGeAlD
Imipramine—HTR7—endothelium—type 2 diabetes mellitus	0.000479	0.0163	CbGeAlD
Imipramine—KCND3—cortex of kidney—type 2 diabetes mellitus	0.000474	0.0161	CbGeAlD
Imipramine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00045	0.0153	CbGeAlD
Imipramine—KCND3—adipose tissue—type 2 diabetes mellitus	0.000438	0.0149	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000407	0.0139	CbGeAlD
Imipramine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000393	0.0134	CbGeAlD
Imipramine—HTR2A—artery—type 2 diabetes mellitus	0.000353	0.012	CbGeAlD
Imipramine—HTR2A—nerve—type 2 diabetes mellitus	0.000351	0.0119	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000349	0.0119	CbGeAlD
Imipramine—SLC22A2—kidney—type 2 diabetes mellitus	0.000346	0.0118	CbGeAlD
Imipramine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000337	0.0114	CbGeAlD
Imipramine—ADRA1B—kidney—type 2 diabetes mellitus	0.000331	0.0112	CbGeAlD
Imipramine—KCND3—liver—type 2 diabetes mellitus	0.000307	0.0105	CbGeAlD
Imipramine—HTR2A—endothelium—type 2 diabetes mellitus	0.000298	0.0102	CbGeAlD
Imipramine—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.000292	0.00992	CbGeAlD
Imipramine—CYP2C18—liver—type 2 diabetes mellitus	0.00028	0.00952	CbGeAlD
Imipramine—CYP3A7—liver—type 2 diabetes mellitus	0.000266	0.00905	CbGeAlD
Imipramine—SLC22A4—kidney—type 2 diabetes mellitus	0.000256	0.00872	CbGeAlD
Imipramine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000254	0.00864	CbGeAlD
Imipramine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000254	0.00863	CbGeAlD
Imipramine—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.00025	0.00849	CbGeAlD
Imipramine—SLC22A1—kidney—type 2 diabetes mellitus	0.000244	0.0083	CbGeAlD
Imipramine—SLC22A3—kidney—type 2 diabetes mellitus	0.000233	0.00793	CbGeAlD
Imipramine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000231	0.00786	CbGeAlD
Imipramine—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000231	0.00786	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000226	0.0077	CbGeAlD
Imipramine—Aprindine—CALM1—type 2 diabetes mellitus	0.000226	0.0768	CrCbGaD
Imipramine—DRD2—retina—type 2 diabetes mellitus	0.00022	0.00749	CbGeAlD
Imipramine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.00022	0.00748	CbGeAlD
Imipramine—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.00021	0.00715	CbGeAlD
Imipramine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000206	0.00701	CbGeAlD
Imipramine—CHRM3—kidney—type 2 diabetes mellitus	0.000202	0.00688	CbGeAlD
Imipramine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000197	0.0067	CbGeAlD
Imipramine—HTR7—kidney—type 2 diabetes mellitus	0.000193	0.00655	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.00019	0.00646	CbGeAlD
Imipramine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000183	0.00624	CbGeAlD
Imipramine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000182	0.0062	CbGeAlD
Imipramine—ORM1—liver—type 2 diabetes mellitus	0.000168	0.00573	CbGeAlD
Imipramine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000168	0.0057	CbGeAlD
Imipramine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000167	0.0057	CbGeAlD
Imipramine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000157	0.00535	CbGeAlD
Imipramine—SLC22A1—liver—type 2 diabetes mellitus	0.000154	0.00525	CbGeAlD
Imipramine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000151	0.00512	CbGeAlD
Imipramine—SLC22A3—liver—type 2 diabetes mellitus	0.000147	0.00501	CbGeAlD
Imipramine—CYP2B6—kidney—type 2 diabetes mellitus	0.000147	0.00501	CbGeAlD
Imipramine—HTR2A—retina—type 2 diabetes mellitus	0.000145	0.00494	CbGeAlD
Imipramine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000141	0.00481	CbGeAlD
Imipramine—CYP2E1—kidney—type 2 diabetes mellitus	0.000138	0.0047	CbGeAlD
Imipramine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000135	0.00458	CbGeAlD
Imipramine—HRH1—adipose tissue—type 2 diabetes mellitus	0.00013	0.00441	CbGeAlD
Imipramine—Benazepril—MTHFR—type 2 diabetes mellitus	0.000126	0.0427	CrCbGaD
Imipramine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000123	0.00418	CbGeAlD
Imipramine—HTR7—liver—type 2 diabetes mellitus	0.000122	0.00414	CbGeAlD
Imipramine—HTR2A—kidney—type 2 diabetes mellitus	0.00012	0.00409	CbGeAlD
Imipramine—CYP2C19—liver—type 2 diabetes mellitus	0.000119	0.00404	CbGeAlD
Imipramine—ADRA1A—liver—type 2 diabetes mellitus	0.000117	0.00399	CbGeAlD
Imipramine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000111	0.00378	CbGeAlD
Imipramine—CYP3A4—kidney—type 2 diabetes mellitus	0.000111	0.00378	CbGeAlD
Imipramine—CYP2D6—kidney—type 2 diabetes mellitus	0.000109	0.00372	CbGeAlD
Imipramine—Benazepril—ACE—type 2 diabetes mellitus	0.000102	0.0348	CrCbGaD
Imipramine—CYP1A2—liver—type 2 diabetes mellitus	9.71e-05	0.0033	CbGeAlD
Imipramine—ABCB1—retina—type 2 diabetes mellitus	9.51e-05	0.00324	CbGeAlD
Imipramine—CYP2B6—liver—type 2 diabetes mellitus	9.31e-05	0.00317	CbGeAlD
Imipramine—ABCB1—nephron tubule—type 2 diabetes mellitus	8.96e-05	0.00305	CbGeAlD
Imipramine—Promethazine—CALM1—type 2 diabetes mellitus	8.93e-05	0.0304	CrCbGaD
Imipramine—CYP2E1—liver—type 2 diabetes mellitus	8.74e-05	0.00297	CbGeAlD
Imipramine—Epinastine—ADRA2A—type 2 diabetes mellitus	8.62e-05	0.0294	CrCbGaD
Imipramine—Cyamemazine—HTR2C—type 2 diabetes mellitus	8.6e-05	0.0293	CrCbGaD
Imipramine—ABCB1—cardiovascular system—type 2 diabetes mellitus	8.05e-05	0.00274	CbGeAlD
Imipramine—ABCB1—kidney—type 2 diabetes mellitus	7.87e-05	0.00268	CbGeAlD
Imipramine—ABCB1—pancreas—type 2 diabetes mellitus	7.82e-05	0.00266	CbGeAlD
Imipramine—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.67e-05	0.00261	CbGeAlD
Imipramine—HTR2A—liver—type 2 diabetes mellitus	7.59e-05	0.00258	CbGeAlD
Imipramine—ABCB1—adipose tissue—type 2 diabetes mellitus	7.1e-05	0.00241	CbGeAlD
Imipramine—CYP3A4—liver—type 2 diabetes mellitus	7.03e-05	0.00239	CbGeAlD
Imipramine—CYP2D6—liver—type 2 diabetes mellitus	6.92e-05	0.00235	CbGeAlD
Imipramine—Chlorpromazine—CALM1—type 2 diabetes mellitus	6.91e-05	0.0235	CrCbGaD
Imipramine—Maprotiline—HTR2C—type 2 diabetes mellitus	6.83e-05	0.0233	CrCbGaD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	6.67e-05	0.000581	CcSEcCtD
Imipramine—Leukopenia—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.000581	CcSEcCtD
Imipramine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	6.64e-05	0.000579	CcSEcCtD
Imipramine—Discomfort—Metformin—type 2 diabetes mellitus	6.63e-05	0.000578	CcSEcCtD
Imipramine—Fatigue—Gliclazide—type 2 diabetes mellitus	6.63e-05	0.000578	CcSEcCtD
Imipramine—Nausea—Glipizide—type 2 diabetes mellitus	6.61e-05	0.000577	CcSEcCtD
Imipramine—Vomiting—Glimepiride—type 2 diabetes mellitus	6.6e-05	0.000576	CcSEcCtD
Imipramine—Vision blurred—Losartan—type 2 diabetes mellitus	6.6e-05	0.000576	CcSEcCtD
Imipramine—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.58e-05	0.000574	CcSEcCtD
Imipramine—Constipation—Gliclazide—type 2 diabetes mellitus	6.58e-05	0.000574	CcSEcCtD
Imipramine—Tremor—Losartan—type 2 diabetes mellitus	6.56e-05	0.000572	CcSEcCtD
Imipramine—Rash—Glimepiride—type 2 diabetes mellitus	6.55e-05	0.000571	CcSEcCtD
Imipramine—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.54e-05	0.000571	CcSEcCtD
Imipramine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.00057	CcSEcCtD
Imipramine—Rash—Sitagliptin—type 2 diabetes mellitus	6.53e-05	0.000569	CcSEcCtD
Imipramine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.52e-05	0.000569	CcSEcCtD
Imipramine—Headache—Glimepiride—type 2 diabetes mellitus	6.51e-05	0.000567	CcSEcCtD
Imipramine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.5e-05	0.000567	CcSEcCtD
Imipramine—Headache—Sitagliptin—type 2 diabetes mellitus	6.49e-05	0.000566	CcSEcCtD
Imipramine—Agitation—Losartan—type 2 diabetes mellitus	6.44e-05	0.000561	CcSEcCtD
Imipramine—Oedema—Metformin—type 2 diabetes mellitus	6.44e-05	0.000561	CcSEcCtD
Imipramine—Tinnitus—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000561	CcSEcCtD
Imipramine—Hypertension—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.00056	CcSEcCtD
Imipramine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.41e-05	0.000559	CcSEcCtD
Imipramine—Flushing—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000558	CcSEcCtD
Imipramine—Infection—Metformin—type 2 diabetes mellitus	6.39e-05	0.000558	CcSEcCtD
Imipramine—Insomnia—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000557	CcSEcCtD
Imipramine—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.35e-05	0.000553	CcSEcCtD
Imipramine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.34e-05	0.000553	CcSEcCtD
Imipramine—Shock—Metformin—type 2 diabetes mellitus	6.33e-05	0.000552	CcSEcCtD
Imipramine—Insomnia—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000551	CcSEcCtD
Imipramine—Malaise—Losartan—type 2 diabetes mellitus	6.32e-05	0.000551	CcSEcCtD
Imipramine—Anxiety—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.000551	CcSEcCtD
Imipramine—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.31e-05	0.00055	CcSEcCtD
Imipramine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.3e-05	0.000549	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000549	CcSEcCtD
Imipramine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.29e-05	0.000548	CcSEcCtD
Imipramine—Somnolence—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000548	CcSEcCtD
Imipramine—Syncope—Losartan—type 2 diabetes mellitus	6.28e-05	0.000548	CcSEcCtD
Imipramine—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.27e-05	0.000547	CcSEcCtD
Imipramine—Leukopenia—Losartan—type 2 diabetes mellitus	6.27e-05	0.000547	CcSEcCtD
Imipramine—Discomfort—Irbesartan—type 2 diabetes mellitus	6.26e-05	0.000546	CcSEcCtD
Imipramine—Skin disorder—Metformin—type 2 diabetes mellitus	6.25e-05	0.000545	CcSEcCtD
Imipramine—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000543	CcSEcCtD
Imipramine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.22e-05	0.000543	CcSEcCtD
Imipramine—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000542	CcSEcCtD
Imipramine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000542	CcSEcCtD
Imipramine—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.2e-05	0.00054	CcSEcCtD
Imipramine—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.00054	CcSEcCtD
Imipramine—Palpitations—Losartan—type 2 diabetes mellitus	6.19e-05	0.00054	CcSEcCtD
Imipramine—Nausea—Glimepiride—type 2 diabetes mellitus	6.17e-05	0.000538	CcSEcCtD
Imipramine—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000537	CcSEcCtD
Imipramine—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.16e-05	0.000537	CcSEcCtD
Imipramine—Nausea—Sitagliptin—type 2 diabetes mellitus	6.15e-05	0.000536	CcSEcCtD
Imipramine—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000536	CcSEcCtD
Imipramine—Asthenia—Glyburide—type 2 diabetes mellitus	6.15e-05	0.000536	CcSEcCtD
Imipramine—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000536	CcSEcCtD
Imipramine—Anorexia—Metformin—type 2 diabetes mellitus	6.13e-05	0.000535	CcSEcCtD
Imipramine—Urticaria—Gliclazide—type 2 diabetes mellitus	6.11e-05	0.000533	CcSEcCtD
Imipramine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.1e-05	0.000532	CcSEcCtD
Imipramine—Alopecia—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000532	CcSEcCtD
Imipramine—Fatigue—Valsartan—type 2 diabetes mellitus	6.09e-05	0.000531	CcSEcCtD
Imipramine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.08e-05	0.00053	CcSEcCtD
Imipramine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.08e-05	0.00053	CcSEcCtD
Imipramine—Oedema—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.00053	CcSEcCtD
Imipramine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.00053	CcSEcCtD
Imipramine—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000529	CcSEcCtD
Imipramine—Pruritus—Glyburide—type 2 diabetes mellitus	6.06e-05	0.000528	CcSEcCtD
Imipramine—Mental disorder—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000527	CcSEcCtD
Imipramine—Constipation—Valsartan—type 2 diabetes mellitus	6.04e-05	0.000527	CcSEcCtD
Imipramine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	6.03e-05	0.0205	CrCbGaD
Imipramine—Infection—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000526	CcSEcCtD
Imipramine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.03e-05	0.000526	CcSEcCtD
Imipramine—Fatigue—Orlistat—type 2 diabetes mellitus	6.02e-05	0.000525	CcSEcCtD
Imipramine—Malnutrition—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000524	CcSEcCtD
Imipramine—Shock—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000521	CcSEcCtD
Imipramine—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.96e-05	0.00052	CcSEcCtD
Imipramine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000519	CcSEcCtD
Imipramine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000519	CcSEcCtD
Imipramine—Anxiety—Losartan—type 2 diabetes mellitus	5.94e-05	0.000518	CcSEcCtD
Imipramine—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000517	CcSEcCtD
Imipramine—Rash—Bromocriptine—type 2 diabetes mellitus	5.91e-05	0.000515	CcSEcCtD
Imipramine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.9e-05	0.000515	CcSEcCtD
Imipramine—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000514	CcSEcCtD
Imipramine—Tension—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000514	CcSEcCtD
Imipramine—Discomfort—Losartan—type 2 diabetes mellitus	5.89e-05	0.000514	CcSEcCtD
Imipramine—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000513	CcSEcCtD
Imipramine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000512	CcSEcCtD
Imipramine—Headache—Bromocriptine—type 2 diabetes mellitus	5.87e-05	0.000512	CcSEcCtD
Imipramine—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.86e-05	0.000511	CcSEcCtD
Imipramine—Nervousness—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000509	CcSEcCtD
Imipramine—Dry mouth—Losartan—type 2 diabetes mellitus	5.83e-05	0.000508	CcSEcCtD
Imipramine—Anorexia—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000505	CcSEcCtD
Imipramine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.78e-05	0.000504	CcSEcCtD
Imipramine—Paraesthesia—Metformin—type 2 diabetes mellitus	5.78e-05	0.000504	CcSEcCtD
Imipramine—Confusional state—Losartan—type 2 diabetes mellitus	5.76e-05	0.000503	CcSEcCtD
Imipramine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.75e-05	0.000502	CcSEcCtD
Imipramine—Somnolence—Metformin—type 2 diabetes mellitus	5.72e-05	0.000499	CcSEcCtD
Imipramine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.72e-05	0.000498	CcSEcCtD
Imipramine—Oedema—Losartan—type 2 diabetes mellitus	5.72e-05	0.000498	CcSEcCtD
Imipramine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.71e-05	0.000498	CcSEcCtD
Imipramine—Infection—Losartan—type 2 diabetes mellitus	5.68e-05	0.000495	CcSEcCtD
Imipramine—Dyspepsia—Metformin—type 2 diabetes mellitus	5.67e-05	0.000494	CcSEcCtD
Imipramine—Carbamazepine—ABCC2—type 2 diabetes mellitus	5.63e-05	0.0192	CrCbGaD
Imipramine—Tremor—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000491	CcSEcCtD
Imipramine—Shock—Losartan—type 2 diabetes mellitus	5.62e-05	0.00049	CcSEcCtD
Imipramine—Urticaria—Valsartan—type 2 diabetes mellitus	5.61e-05	0.00049	CcSEcCtD
Imipramine—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.61e-05	0.000489	CcSEcCtD
Imipramine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.6e-05	0.000488	CcSEcCtD
Imipramine—Decreased appetite—Metformin—type 2 diabetes mellitus	5.59e-05	0.000488	CcSEcCtD
Imipramine—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.59e-05	0.000487	CcSEcCtD
Imipramine—Tachycardia—Losartan—type 2 diabetes mellitus	5.58e-05	0.000486	CcSEcCtD
Imipramine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000486	CcSEcCtD
Imipramine—Nausea—Bromocriptine—type 2 diabetes mellitus	5.57e-05	0.000485	CcSEcCtD
Imipramine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.56e-05	0.000484	CcSEcCtD
Imipramine—Fatigue—Metformin—type 2 diabetes mellitus	5.55e-05	0.000484	CcSEcCtD
Imipramine—Urticaria—Orlistat—type 2 diabetes mellitus	5.55e-05	0.000484	CcSEcCtD
Imipramine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.53e-05	0.000482	CcSEcCtD
Imipramine—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.52e-05	0.000481	CcSEcCtD
Imipramine—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.52e-05	0.000481	CcSEcCtD
Imipramine—Asthenia—Gliclazide—type 2 diabetes mellitus	5.52e-05	0.000481	CcSEcCtD
Imipramine—Agitation—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000481	CcSEcCtD
Imipramine—Constipation—Metformin—type 2 diabetes mellitus	5.5e-05	0.00048	CcSEcCtD
Imipramine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000476	CcSEcCtD
Imipramine—Anorexia—Losartan—type 2 diabetes mellitus	5.45e-05	0.000475	CcSEcCtD
Imipramine—Vomiting—Glyburide—type 2 diabetes mellitus	5.45e-05	0.000475	CcSEcCtD
Imipramine—Pruritus—Gliclazide—type 2 diabetes mellitus	5.44e-05	0.000475	CcSEcCtD
Imipramine—Malaise—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000472	CcSEcCtD
Imipramine—Rash—Glyburide—type 2 diabetes mellitus	5.4e-05	0.000471	CcSEcCtD
Imipramine—Somnolence—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000471	CcSEcCtD
Imipramine—Dermatitis—Glyburide—type 2 diabetes mellitus	5.4e-05	0.000471	CcSEcCtD
Imipramine—Syncope—Ramipril—type 2 diabetes mellitus	5.39e-05	0.00047	CcSEcCtD
Imipramine—Leukopenia—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000469	CcSEcCtD
Imipramine—Headache—Glyburide—type 2 diabetes mellitus	5.37e-05	0.000468	CcSEcCtD
Imipramine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000466	CcSEcCtD
Imipramine—Palpitations—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000463	CcSEcCtD
Imipramine—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.3e-05	0.000462	CcSEcCtD
Imipramine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.00046	CcSEcCtD
Imipramine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.28e-05	0.00046	CcSEcCtD
Imipramine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.26e-05	0.000459	CcSEcCtD
Imipramine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.26e-05	0.000459	CcSEcCtD
Imipramine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.000457	CcSEcCtD
Imipramine—Fatigue—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.000457	CcSEcCtD
Imipramine—Convulsion—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000454	CcSEcCtD
Imipramine—Constipation—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000453	CcSEcCtD
Imipramine—Insomnia—Losartan—type 2 diabetes mellitus	5.17e-05	0.000451	CcSEcCtD
Imipramine—Maprotiline—CYP1A2—type 2 diabetes mellitus	5.16e-05	0.0176	CrCbGaD
Imipramine—Paraesthesia—Losartan—type 2 diabetes mellitus	5.13e-05	0.000448	CcSEcCtD
Imipramine—Urticaria—Metformin—type 2 diabetes mellitus	5.11e-05	0.000446	CcSEcCtD
Imipramine—Anxiety—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000444	CcSEcCtD
Imipramine—Nausea—Glyburide—type 2 diabetes mellitus	5.09e-05	0.000444	CcSEcCtD
Imipramine—Abdominal pain—Metformin—type 2 diabetes mellitus	5.09e-05	0.000444	CcSEcCtD
Imipramine—Dizziness—Gliclazide—type 2 diabetes mellitus	5.09e-05	0.000444	CcSEcCtD
Imipramine—Somnolence—Losartan—type 2 diabetes mellitus	5.08e-05	0.000443	CcSEcCtD
Imipramine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	5.08e-05	0.0173	CrCbGaD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000443	CcSEcCtD
Imipramine—Asthenia—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000442	CcSEcCtD
Imipramine—Discomfort—Ramipril—type 2 diabetes mellitus	5.05e-05	0.00044	CcSEcCtD
Imipramine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.03e-05	0.000439	CcSEcCtD
Imipramine—Asthenia—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000437	CcSEcCtD
Imipramine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5e-05	0.000436	CcSEcCtD
Imipramine—Pruritus—Valsartan—type 2 diabetes mellitus	5e-05	0.000436	CcSEcCtD
Imipramine—Dry mouth—Ramipril—type 2 diabetes mellitus	5e-05	0.000436	CcSEcCtD
Imipramine—Mianserin—ADRA2A—type 2 diabetes mellitus	4.99e-05	0.017	CrCbGaD
Imipramine—ABCB1—liver—type 2 diabetes mellitus	4.98e-05	0.00169	CbGeAlD
Imipramine—Decreased appetite—Losartan—type 2 diabetes mellitus	4.97e-05	0.000433	CcSEcCtD
Imipramine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000433	CcSEcCtD
Imipramine—Confusional state—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000431	CcSEcCtD
Imipramine—Pruritus—Orlistat—type 2 diabetes mellitus	4.94e-05	0.000431	CcSEcCtD
Imipramine—Fatigue—Losartan—type 2 diabetes mellitus	4.93e-05	0.00043	CcSEcCtD
Imipramine—Oedema—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000427	CcSEcCtD
Imipramine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000427	CcSEcCtD
Imipramine—Vomiting—Gliclazide—type 2 diabetes mellitus	4.89e-05	0.000426	CcSEcCtD
Imipramine—Constipation—Losartan—type 2 diabetes mellitus	4.89e-05	0.000426	CcSEcCtD
Imipramine—Rash—Gliclazide—type 2 diabetes mellitus	4.85e-05	0.000423	CcSEcCtD
Imipramine—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.85e-05	0.000423	CcSEcCtD
Imipramine—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000422	CcSEcCtD
Imipramine—Urticaria—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000421	CcSEcCtD
Imipramine—Shock—Ramipril—type 2 diabetes mellitus	4.82e-05	0.00042	CcSEcCtD
Imipramine—Headache—Gliclazide—type 2 diabetes mellitus	4.82e-05	0.00042	CcSEcCtD
Imipramine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000419	CcSEcCtD
Imipramine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000419	CcSEcCtD
Imipramine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000419	CcSEcCtD
Imipramine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000418	CcSEcCtD
Imipramine—Tachycardia—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000417	CcSEcCtD
Imipramine—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000417	CcSEcCtD
Imipramine—Skin disorder—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000415	CcSEcCtD
Imipramine—Olopatadine—CYP3A4—type 2 diabetes mellitus	4.75e-05	0.0162	CrCbGaD
Imipramine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000413	CcSEcCtD
Imipramine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.71e-05	0.000411	CcSEcCtD
Imipramine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.67e-05	0.000408	CcSEcCtD
Imipramine—Dizziness—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000408	CcSEcCtD
Imipramine—Anorexia—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000407	CcSEcCtD
Imipramine—Dizziness—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000403	CcSEcCtD
Imipramine—Asthenia—Metformin—type 2 diabetes mellitus	4.62e-05	0.000403	CcSEcCtD
Imipramine—Mianserin—HTR2C—type 2 diabetes mellitus	4.59e-05	0.0156	CrCbGaD
Imipramine—Nausea—Gliclazide—type 2 diabetes mellitus	4.57e-05	0.000398	CcSEcCtD
Imipramine—Clomipramine—ADRA2A—type 2 diabetes mellitus	4.56e-05	0.0155	CrCbGaD
Imipramine—Pruritus—Metformin—type 2 diabetes mellitus	4.55e-05	0.000397	CcSEcCtD
Imipramine—Urticaria—Losartan—type 2 diabetes mellitus	4.54e-05	0.000396	CcSEcCtD
Imipramine—Abdominal pain—Losartan—type 2 diabetes mellitus	4.52e-05	0.000394	CcSEcCtD
Imipramine—Body temperature increased—Losartan—type 2 diabetes mellitus	4.52e-05	0.000394	CcSEcCtD
Imipramine—Vomiting—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000392	CcSEcCtD
Imipramine—Rash—Valsartan—type 2 diabetes mellitus	4.46e-05	0.000389	CcSEcCtD
Imipramine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.45e-05	0.000388	CcSEcCtD
Imipramine—Vomiting—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000387	CcSEcCtD
Imipramine—Insomnia—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000387	CcSEcCtD
Imipramine—Headache—Valsartan—type 2 diabetes mellitus	4.43e-05	0.000386	CcSEcCtD
Imipramine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.4e-05	0.000384	CcSEcCtD
Imipramine—Rash—Orlistat—type 2 diabetes mellitus	4.4e-05	0.000384	CcSEcCtD
Imipramine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000384	CcSEcCtD
Imipramine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.4e-05	0.000384	CcSEcCtD
Imipramine—Headache—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000381	CcSEcCtD
Imipramine—Asthenia—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.00038	CcSEcCtD
Imipramine—Somnolence—Ramipril—type 2 diabetes mellitus	4.36e-05	0.00038	CcSEcCtD
Imipramine—Alimemazine—CYP3A4—type 2 diabetes mellitus	4.34e-05	0.0148	CrCbGaD
Imipramine—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000376	CcSEcCtD
Imipramine—Pruritus—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000375	CcSEcCtD
Imipramine—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000371	CcSEcCtD
Imipramine—Dizziness—Metformin—type 2 diabetes mellitus	4.26e-05	0.000371	CcSEcCtD
Imipramine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000369	CcSEcCtD
Imipramine—Fatigue—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000368	CcSEcCtD
Imipramine—Clomipramine—HTR2C—type 2 diabetes mellitus	4.2e-05	0.0143	CrCbGaD
Imipramine—Trimipramine—ADRA2A—type 2 diabetes mellitus	4.2e-05	0.0143	CrCbGaD
Imipramine—Nausea—Valsartan—type 2 diabetes mellitus	4.2e-05	0.000366	CcSEcCtD
Imipramine—Constipation—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000365	CcSEcCtD
Imipramine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000362	CcSEcCtD
Imipramine—Nausea—Orlistat—type 2 diabetes mellitus	4.15e-05	0.000362	CcSEcCtD
Imipramine—Nortriptyline—HTR2C—type 2 diabetes mellitus	4.11e-05	0.014	CrCbGaD
Imipramine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	4.1e-05	0.014	CrCbGaD
Imipramine—Asthenia—Losartan—type 2 diabetes mellitus	4.1e-05	0.000358	CcSEcCtD
Imipramine—Vomiting—Metformin—type 2 diabetes mellitus	4.09e-05	0.000357	CcSEcCtD
Imipramine—Rash—Metformin—type 2 diabetes mellitus	4.06e-05	0.000354	CcSEcCtD
Imipramine—Dermatitis—Metformin—type 2 diabetes mellitus	4.05e-05	0.000354	CcSEcCtD
Imipramine—Pruritus—Losartan—type 2 diabetes mellitus	4.04e-05	0.000353	CcSEcCtD
Imipramine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000352	CcSEcCtD
Imipramine—Headache—Metformin—type 2 diabetes mellitus	4.03e-05	0.000352	CcSEcCtD
Imipramine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.00035	CcSEcCtD
Imipramine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	4.01e-05	0.0137	CrCbGaD
Imipramine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000349	CcSEcCtD
Imipramine—Doxepin—ADRA2A—type 2 diabetes mellitus	4e-05	0.0136	CrCbGaD
Imipramine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	3.99e-05	0.0136	CrCbGaD
Imipramine—Epinastine—CYP3A4—type 2 diabetes mellitus	3.97e-05	0.0135	CrCbGaD
Imipramine—Diarrhoea—Losartan—type 2 diabetes mellitus	3.91e-05	0.000341	CcSEcCtD
Imipramine—Urticaria—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000339	CcSEcCtD
Imipramine—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000338	CcSEcCtD
Imipramine—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000338	CcSEcCtD
Imipramine—Trimipramine—HTR2C—type 2 diabetes mellitus	3.87e-05	0.0132	CrCbGaD
Imipramine—Vomiting—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000337	CcSEcCtD
Imipramine—Rash—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000334	CcSEcCtD
Imipramine—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000334	CcSEcCtD
Imipramine—Nausea—Metformin—type 2 diabetes mellitus	3.82e-05	0.000333	CcSEcCtD
Imipramine—Headache—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000332	CcSEcCtD
Imipramine—Dizziness—Losartan—type 2 diabetes mellitus	3.78e-05	0.00033	CcSEcCtD
Imipramine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	3.78e-05	0.0129	CrCbGaD
Imipramine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	3.76e-05	0.0128	CrCbGaD
Imipramine—Mequitazine—CYP3A4—type 2 diabetes mellitus	3.73e-05	0.0127	CrCbGaD
Imipramine—Doxepin—HTR2C—type 2 diabetes mellitus	3.68e-05	0.0125	CrCbGaD
Imipramine—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	3.65e-05	0.0124	CrCbGaD
Imipramine—Vomiting—Losartan—type 2 diabetes mellitus	3.63e-05	0.000317	CcSEcCtD
Imipramine—Nausea—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000315	CcSEcCtD
Imipramine—Rash—Losartan—type 2 diabetes mellitus	3.6e-05	0.000314	CcSEcCtD
Imipramine—Dermatitis—Losartan—type 2 diabetes mellitus	3.6e-05	0.000314	CcSEcCtD
Imipramine—Headache—Losartan—type 2 diabetes mellitus	3.58e-05	0.000312	CcSEcCtD
Imipramine—Promazine—ADRA2A—type 2 diabetes mellitus	3.56e-05	0.0121	CrCbGaD
Imipramine—Asthenia—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000307	CcSEcCtD
Imipramine—Pruritus—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000302	CcSEcCtD
Imipramine—Mianserin—CYP1A2—type 2 diabetes mellitus	3.47e-05	0.0118	CrCbGaD
Imipramine—Nausea—Losartan—type 2 diabetes mellitus	3.4e-05	0.000296	CcSEcCtD
Imipramine—Desipramine—HTR2C—type 2 diabetes mellitus	3.38e-05	0.0115	CrCbGaD
Imipramine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000292	CcSEcCtD
Imipramine—Promazine—HTR2C—type 2 diabetes mellitus	3.27e-05	0.0111	CrCbGaD
Imipramine—Nortriptyline—CYP2E1—type 2 diabetes mellitus	3.26e-05	0.0111	CrCbGaD
Imipramine—Dizziness—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000283	CcSEcCtD
Imipramine—Oxcarbazepine—ALB—type 2 diabetes mellitus	3.19e-05	0.0109	CrCbGaD
Imipramine—Clomipramine—CYP1A2—type 2 diabetes mellitus	3.17e-05	0.0108	CrCbGaD
Imipramine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	3.13e-05	0.0107	CrCbGaD
Imipramine—Vomiting—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000272	CcSEcCtD
Imipramine—Nortriptyline—CYP1A2—type 2 diabetes mellitus	3.1e-05	0.0105	CrCbGaD
Imipramine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	3.09e-05	0.0105	CrCbGaD
Imipramine—Rash—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000269	CcSEcCtD
Imipramine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000269	CcSEcCtD
Imipramine—Headache—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000268	CcSEcCtD
Imipramine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	3e-05	0.0102	CrCbGaD
Imipramine—Nausea—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000254	CcSEcCtD
Imipramine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	2.88e-05	0.00981	CrCbGaD
Imipramine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	2.86e-05	0.00975	CrCbGaD
Imipramine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	2.85e-05	0.00971	CrCbGaD
Imipramine—Amitriptyline—HTR2C—type 2 diabetes mellitus	2.85e-05	0.0097	CrCbGaD
Imipramine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	2.85e-05	0.00969	CrCbGaD
Imipramine—Doxepin—CYP1A2—type 2 diabetes mellitus	2.78e-05	0.00946	CrCbGaD
Imipramine—Desipramine—CYP2E1—type 2 diabetes mellitus	2.68e-05	0.00913	CrCbGaD
Imipramine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	2.65e-05	0.00904	CrCbGaD
Imipramine—Desipramine—CYP1A2—type 2 diabetes mellitus	2.55e-05	0.00868	CrCbGaD
Imipramine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	2.54e-05	0.00864	CrCbGaD
Imipramine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	2.49e-05	0.00848	CrCbGaD
Imipramine—Promazine—CYP1A2—type 2 diabetes mellitus	2.47e-05	0.00841	CrCbGaD
Imipramine—Acepromazine—ALB—type 2 diabetes mellitus	2.41e-05	0.0082	CrCbGaD
Imipramine—Thioproperazine—ALB—type 2 diabetes mellitus	2.35e-05	0.00801	CrCbGaD
Imipramine—Pipotiazine—ALB—type 2 diabetes mellitus	2.32e-05	0.00788	CrCbGaD
Imipramine—Mianserin—CYP3A4—type 2 diabetes mellitus	2.29e-05	0.00781	CrCbGaD
Imipramine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	2.29e-05	0.00778	CrCbGaD
Imipramine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	2.26e-05	0.00769	CrCbGaD
Imipramine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	2.17e-05	0.0074	CrCbGaD
Imipramine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	2.15e-05	0.00732	CrCbGaD
Imipramine—Clomipramine—CYP3A4—type 2 diabetes mellitus	2.1e-05	0.00714	CrCbGaD
Imipramine—Nortriptyline—CYP3A4—type 2 diabetes mellitus	2.05e-05	0.00698	CrCbGaD
Imipramine—Trimipramine—CYP3A4—type 2 diabetes mellitus	1.93e-05	0.00657	CrCbGaD
Imipramine—Doxepin—CYP3A4—type 2 diabetes mellitus	1.84e-05	0.00626	CrCbGaD
Imipramine—Clomipramine—ALB—type 2 diabetes mellitus	1.83e-05	0.00623	CrCbGaD
Imipramine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	1.79e-05	0.0061	CrCbGaD
Imipramine—Nortriptyline—ALB—type 2 diabetes mellitus	1.79e-05	0.00609	CrCbGaD
Imipramine—Desipramine—CYP3A4—type 2 diabetes mellitus	1.69e-05	0.00575	CrCbGaD
Imipramine—Promazine—CYP3A4—type 2 diabetes mellitus	1.64e-05	0.00557	CrCbGaD
Imipramine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.44e-05	0.0049	CrCbGaD
Imipramine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	1.42e-05	0.00484	CrCbGaD
Imipramine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.26e-05	0.00427	CrCbGaD
Imipramine—Amitriptyline—ALB—type 2 diabetes mellitus	1.24e-05	0.00423	CrCbGaD
Imipramine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.67e-07	1.18e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.65e-07	1.18e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.64e-07	1.18e-05	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	9.6e-07	1.17e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	9.59e-07	1.17e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	9.56e-07	1.17e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	9.53e-07	1.17e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.52e-07	1.16e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.52e-07	1.16e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.51e-07	1.16e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	9.51e-07	1.16e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.49e-07	1.16e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.49e-07	1.16e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	9.49e-07	1.16e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.46e-07	1.16e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.46e-07	1.16e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	9.45e-07	1.16e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	9.44e-07	1.15e-05	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.44e-07	1.15e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.43e-07	1.15e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.43e-07	1.15e-05	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.39e-07	1.15e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.35e-07	1.14e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	9.35e-07	1.14e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.34e-07	1.14e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.34e-07	1.14e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	9.34e-07	1.14e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	9.34e-07	1.14e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.32e-07	1.14e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.32e-07	1.14e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.3e-07	1.14e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.29e-07	1.14e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.28e-07	1.14e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	9.27e-07	1.13e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.24e-07	1.13e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	9.19e-07	1.12e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.1e-07	1.11e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.1e-07	1.11e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	9.1e-07	1.11e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.1e-07	1.11e-05	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	9.07e-07	1.11e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	9.04e-07	1.11e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	9e-07	1.1e-05	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.99e-07	1.1e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.96e-07	1.1e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	8.95e-07	1.09e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	8.95e-07	1.09e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.94e-07	1.09e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	8.91e-07	1.09e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.91e-07	1.09e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.91e-07	1.09e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	8.9e-07	1.09e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.89e-07	1.09e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	8.88e-07	1.09e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	8.88e-07	1.09e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	8.88e-07	1.09e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.85e-07	1.08e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.84e-07	1.08e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	8.79e-07	1.08e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.79e-07	1.08e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.77e-07	1.07e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.74e-07	1.07e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.71e-07	1.07e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.7e-07	1.06e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	8.69e-07	1.06e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.65e-07	1.06e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.57e-07	1.05e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.54e-07	1.04e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	8.53e-07	1.04e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.53e-07	1.04e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.42e-07	1.03e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	8.36e-07	1.02e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.36e-07	1.02e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.33e-07	1.02e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	8.32e-07	1.02e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.29e-07	1.01e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.21e-07	1e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	8.19e-07	1e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.19e-07	1e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	8.16e-07	9.99e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.16e-07	9.98e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.16e-07	9.98e-06	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.15e-07	9.97e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.15e-07	9.97e-06	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.14e-07	9.95e-06	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.11e-07	9.92e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.11e-07	9.91e-06	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.08e-07	9.89e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.08e-07	9.88e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.06e-07	9.86e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	8.04e-07	9.83e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.04e-07	9.83e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.03e-07	9.82e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.01e-07	9.8e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.01e-07	9.8e-06	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.01e-07	9.79e-06	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.98e-07	9.77e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.98e-07	9.76e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.96e-07	9.73e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.94e-07	9.71e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.93e-07	9.7e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.91e-07	9.68e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.89e-07	9.66e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.88e-07	9.64e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.86e-07	9.61e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	7.84e-07	9.59e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	7.79e-07	9.52e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	7.76e-07	9.49e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.76e-07	9.49e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.71e-07	9.44e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	7.71e-07	9.44e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	7.69e-07	9.41e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	7.68e-07	9.39e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.68e-07	9.39e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	7.67e-07	9.38e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.66e-07	9.36e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.63e-07	9.34e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.63e-07	9.33e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.62e-07	9.32e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.59e-07	9.29e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	7.58e-07	9.27e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.57e-07	9.26e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.56e-07	9.24e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.55e-07	9.24e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.54e-07	9.22e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.54e-07	9.22e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.53e-07	9.2e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.51e-07	9.19e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.5e-07	9.17e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.49e-07	9.16e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	7.48e-07	9.15e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.48e-07	9.14e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.42e-07	9.07e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	7.41e-07	9.07e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	7.41e-07	9.06e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.4e-07	9.06e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.4e-07	9.05e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.39e-07	9.04e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.36e-07	9.01e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.36e-07	9e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.34e-07	8.98e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.33e-07	8.97e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.33e-07	8.97e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.28e-07	8.91e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.27e-07	8.89e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.25e-07	8.87e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.25e-07	8.86e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.16e-07	8.76e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.16e-07	8.76e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.16e-07	8.75e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.15e-07	8.75e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.14e-07	8.73e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.1e-07	8.69e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	7.05e-07	8.63e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.04e-07	8.61e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.02e-07	8.59e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.02e-07	8.59e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7e-07	8.56e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	6.99e-07	8.56e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	6.98e-07	8.54e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.97e-07	8.52e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.94e-07	8.48e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.91e-07	8.45e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.89e-07	8.43e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	6.88e-07	8.41e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.86e-07	8.39e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	6.85e-07	8.38e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.84e-07	8.37e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.84e-07	8.37e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.83e-07	8.36e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.82e-07	8.34e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.8e-07	8.32e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.8e-07	8.31e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	6.75e-07	8.25e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	6.75e-07	8.25e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.73e-07	8.23e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.71e-07	8.21e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	6.71e-07	8.21e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	6.7e-07	8.19e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	6.67e-07	8.16e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.64e-07	8.13e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	6.59e-07	8.06e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	6.55e-07	8.01e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.52e-07	7.97e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.45e-07	7.89e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.39e-07	7.82e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.32e-07	7.74e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	6.3e-07	7.7e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.29e-07	7.7e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.28e-07	7.68e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.27e-07	7.67e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.26e-07	7.66e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.24e-07	7.63e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.2e-07	7.59e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.18e-07	7.56e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.18e-07	7.56e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.17e-07	7.55e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.17e-07	7.55e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.16e-07	7.54e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.16e-07	7.53e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.14e-07	7.51e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.12e-07	7.48e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.06e-07	7.41e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.04e-07	7.39e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	6.03e-07	7.38e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	6.02e-07	7.37e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.01e-07	7.35e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	5.97e-07	7.31e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.91e-07	7.23e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.89e-07	7.2e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	5.82e-07	7.12e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.81e-07	7.11e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.72e-07	6.99e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.72e-07	6.99e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	5.61e-07	6.87e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.49e-07	6.71e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.46e-07	6.68e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.23e-07	6.39e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.23e-07	6.39e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	5.19e-07	6.34e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.13e-07	6.27e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.06e-07	6.19e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.04e-07	6.16e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.03e-07	6.15e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.82e-07	5.9e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.82e-07	5.89e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.74e-07	5.8e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.73e-07	5.79e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.72e-07	5.77e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.7e-07	5.75e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.66e-07	5.69e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.64e-07	5.68e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.61e-07	5.64e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	4.46e-07	5.46e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.45e-07	5.44e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.41e-07	5.4e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.41e-07	5.4e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.37e-07	5.35e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	4.37e-07	5.35e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.36e-07	5.34e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.35e-07	5.32e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.34e-07	5.3e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.29e-07	5.25e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.28e-07	5.24e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.03e-07	4.93e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.37e-07	4.12e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.29e-07	4.03e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.1e-07	3.79e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.63e-07	3.21e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.03e-07	2.48e-06	CbGpPWpGaD
